NCT04392635

Brief Summary

The purpose of this study is to assess the safety and ease of use of a TauTona Pneumoperitoneum Assist Device (TPAD) to assist with obtaining peritoneal access with a Veress needle, and for placing a primary trocar, during laparoscopic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 19, 2020

Completed
2.1 years until next milestone

Study Start

First participant enrolled

June 20, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2024

Completed
1 year until next milestone

Results Posted

Study results publicly available

July 1, 2025

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

2 years

First QC Date

May 13, 2020

Results QC Date

June 11, 2025

Last Update Submit

June 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Surgeon Satisfaction Survey

    The surgeon completes a LIKERT scale satisfaction survey related to the TPAD to assess its ease of use. Scale range 1-5 (higher scores correspond to higher satisfaction)

    up to 1 minute on day of surgery

Secondary Outcomes (2)

  • Time From Incision for Veress Needle Insertion to Start of Insufflation

    Up to approximately 2 minutes

  • Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0

    Continuous from start of surgery through postoperative day 7

Study Arms (2)

TauTona Pneumoperitoneum Assist Device (TPAD)

EXPERIMENTAL

Participants will receive investigational TPAD device during laparoscopic surgery. The TPAD was used to aid Veress needle insertion in place of surgical tools such as clamps. The TPAD was applied to the patient prior to Veress needle entry and removed after insufflation was completed.

Device: TauTona Pneumoperitoneum Assist Device (TPAD)

Standard of Care (SOC)

ACTIVE COMPARATOR

Participants will receive SOC included both direct (unassisted) entry and assisted entry using clamps, if needed, to aid in Veress needle insertion. Upon confirmation that the Veress needle was in the correct location (e.g. drop test), insufflation was initiated.

Procedure: Standard of Care (SOC)

Interventions

The TPAD is an experimental device used to assist with placement of Veress needle during laparoscopic surgery.

TauTona Pneumoperitoneum Assist Device (TPAD)

Standard of Care was used for Veress needle insertion.

Standard of Care (SOC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>/= 18
  • Scheduled for laparoscopic surgery
  • Able to understand and willing to sign a written informed consent form

You may not qualify if:

  • Age \< 18
  • Any situation where blind, peri-umbilical passage of a Veress needle is contraindicated.
  • Any situation where patients have suspected or confirmed intra-abdominal adhesions involving the peri-umbilical abdominal wall.
  • Any situation where patients have a suspected or confirmed umbilical hernia or peri-umbilical ventral hernia.
  • Any situation where there is not intact, uncompromised skin of the peri-umbilical region where the device is to be placed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94304, United States

Location

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Study Team
Organization
Stanford University

Study Officials

  • James R Korndorffer Jr, MD MHPE FACS

    Stanford University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2020

First Posted

May 19, 2020

Study Start

June 20, 2022

Primary Completion

June 17, 2024

Study Completion

June 17, 2024

Last Updated

July 1, 2025

Results First Posted

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations